About the Study

RSV, Respiratory Syncytial Virus, is a very common, highly contagious virus that causes infection of the respiratory tract in people of all ages. In the Rochester climate, symptoms usually develop during fall and winter. In many people, the disease is quite mild and can produce cold-like symptoms. However, in very young children, older adults, and people with chronic diseases such as COPD, it can be very serious and result in hospitalization or death. There is currently no vaccine available to the general public to prevent this infection and antibiotics are not helpful as this infection is viral.

The purpose of this research is to find a safe and effective vaccine for RSV.

The study will last approximately 4 years with 5 visits to our office. There is a 50% chance of a placebo for this study. Compensation is available for time and travel is available for those who qualify. Study-related care is available to participants at no cost and health insurance is not required nor needed.

Qualifications

  • Be 60 years of age or older
  • Be in stable health
  • No allergy to latex
  • Please note, other conditions may apply